Ken Griffin Medifast Inc Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$19.49 - $37.51 $4.39 Million - $8.45 Million	225,200 Added 179.87%	350,400 $7.65 Million
Q1 2024 May 15, 2024	BUY	$34.57 - $70.23 $2.24 Million - $4.55 Million	64,800 Added 107.28%	125,200 $4.8 Million
Q4 2023 Feb 14, 2024	BUY	$62.17 - $76.46 $1.83 Million - $2.26 Million	29,500 Added 95.47%	60,400 $4.06 Million
Q3 2023 Nov 14, 2023	SELL	$74.85 - $107.06 $52,394 - $74,942	-700 Reduced 2.22%	30,900 $2.31 Million
Q2 2023 Aug 14, 2023	SELL	$78.7 - $102.49 $920,790 - $1.2 Million	-11,700 Reduced 27.02%	31,600 $2.91 Million
Q1 2023 May 15, 2023	SELL	$97.09 - $130.31 $689,339 - $925,201	-7,100 Reduced 14.09%	43,300 $4.49 Million
Q4 2022 Feb 14, 2023	BUY	$103.38 - $126.05 $2.61 Million - $3.18 Million	25,200 Added 100.0%	50,400 $5.81 Million
Q3 2022 Nov 14, 2022	BUY	$108.36 - $187.67 $1.31 Million - $2.27 Million	12,100 Added 92.37%	25,200 $2.73 Million

169

10.1M

542K

545K

Ticker MED
Exchange NYSE
Sector Consumer Cyclical
Industry Personal Services
Shares Outstandng 11,017,900
Market Cap $214M
Description
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft se...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.